BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34180731)

  • 1. The Significance of Squamous Histology on Clinical Outcomes and PD-L1 Expression in Bladder Cancer.
    Gordetsky JB; Montgomery KW; Giannico GA; Rais-Bahrami S; Thapa P; Boorjian S; Frank I; Cheville J
    Int J Surg Pathol; 2022 Feb; 30(1):6-14. PubMed ID: 34180731
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes of squamous histology in bladder cancer: a population-based study.
    Izard JP; Siemens DR; Mackillop WJ; Wei X; Leveridge MJ; Berman DM; Peng Y; Booth CM
    Urol Oncol; 2015 Oct; 33(10):425.e7-13. PubMed ID: 26199176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and prognostic utility of PD-L1 in patients with squamous cell carcinoma of the bladder.
    Owyong M; Lotan Y; Kapur P; Panwar V; McKenzie T; Lee TK; Zi X; Martin JW; Mosbah A; Abol-Enein H; Ghoneim M; Youssef RF
    Urol Oncol; 2019 Jul; 37(7):478-484. PubMed ID: 30910351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder.
    Minato A; Noguchi H; Tomisaki I; Fukuda A; Kubo T; Nakayama T; Fujimoto N
    Cancer Control; 2018; 25(1):1073274818800269. PubMed ID: 30213195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of pretreatment inflammatory markers in variant histologies of the bladder: is inflammation linked to survival after radical cystectomy?
    Rodler S; Buchner A; Ledderose ST; Eismann L; Volz Y; Pfitzinger P; Kretschmer A; Schulz GB; Karl A; Schlenker B; Stief CG; Jokisch F
    World J Urol; 2021 Jul; 39(7):2537-2543. PubMed ID: 33084922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor in urothelial carcinoma.
    Zhong Q; Shou J; Ying J; Ling Y; Yu Y; Shen Z; Zhang Y; Li N; Shi Y; Zhou A
    Future Oncol; 2021 Aug; 17(22):2893-2905. PubMed ID: 34189951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of squamous histology on survival in patients with muscle-invasive bladder cancer.
    Matulay JT; Woldu SL; Lim A; Narayan VM; Li G; Kamat AM; Anderson CB
    Urol Oncol; 2019 Jun; 37(6):353.e17-353.e24. PubMed ID: 30704959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation.
    Morsch R; Rose M; Maurer A; Cassataro MA; Braunschweig T; Knüchel R; Vögeli TA; Ecke T; Eckstein M; Weyerer V; Esposito I; Ackermann M; Niegisch G; Gaisa NT;
    BMC Cancer; 2020 Mar; 20(1):230. PubMed ID: 32188412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter- and intraobserver agreement of programmed death ligand 1 scoring in head and neck squamous cell carcinoma, urothelial carcinoma and breast carcinoma.
    Downes MR; Slodkowska E; Katabi N; Jungbluth AA; Xu B
    Histopathology; 2020 Jan; 76(2):191-200. PubMed ID: 31243779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort.
    Martin JW; Vernez SL; Lotan Y; Abdelhalim A; Dutta R; Shokeir A; Abol-Enein H; Mosbah A; Ghoneim M; Youssef RF
    World J Urol; 2018 Nov; 36(11):1835-1843. PubMed ID: 29761225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-L1 expression in tumor cells and the immunologic milieu of bladder carcinomas: a pathologic review of 165 cases.
    Davick JJ; Frierson HF; Smolkin M; Gru AA
    Hum Pathol; 2018 Nov; 81():184-191. PubMed ID: 29969606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-L1 expression in tumor-infiltrating lymphocytes (TILs) as an independent predictor of prognosis in patients with pN0 bladder cancer undergoing radical cystectomy.
    Murakami Y; Matsumoto K; Shimizu Y; Ikeda M; Amano N; Shimura S; Ishii D; Sato Y; Iwamura M
    Urol Oncol; 2021 Mar; 39(3):195.e15-195.e23. PubMed ID: 33071109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squamous Differentiation Predicts Poor Response to Cisplatin-Based Chemotherapy and Unfavorable Prognosis in Urothelial Carcinoma of the Urinary Bladder.
    Minato A; Fujimoto N; Kubo T
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1063-e1067. PubMed ID: 28803791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do pure squamous cell carcinomas and urothelial carcinomas have similar prognosis after radical cystectomy?
    Balci U; Ozer K; Gorgel SN; Sefik E; Girgin C; Dincel C
    World J Urol; 2013 Oct; 31(5):1177-82. PubMed ID: 22544338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordance of PD-L1 expression in matched urothelial bladder cancer specimens.
    de Jong JJ; Stoop H; Nieboer D; Boormans JL; van Leenders GJLH
    Histopathology; 2018 Dec; 73(6):983-989. PubMed ID: 30003574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased PD-L1 expression in high-grade bladder cancer with squamous cell differentiation in Bulgarian and French patients' samples.
    Gulinac M; Dikov D; Velikova T; Belovezhdov V
    Ann Diagn Pathol; 2020 Dec; 49():151640. PubMed ID: 33069081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinicopathological and prognostic value of PD-L1 in urothelial carcinoma: a meta-analysis.
    Wen Y; Chen Y; Duan X; Zhu W; Cai C; Deng T; Zeng G
    Clin Exp Med; 2019 Nov; 19(4):407-416. PubMed ID: 31407099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of PD-L1 and B7-H3 expression as a predictor of response to adjuvant chemotherapy in bladder cancer.
    Mahmoud AM; Frank I; Orme JJ; Lavoie RR; Thapa P; Costello BA; Cheville JC; Gupta S; Dong H; Lucien F
    BMC Urol; 2022 Jun; 22(1):90. PubMed ID: 35751046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of the expression of PD-L1 in non-small cell lung cancer.
    Montero MA; Aricak O; Kis L; Yoshikawa A; De Petris L; Grundberg O; Pham HHN; Roden AC; Fukuoka J; Attanoos R; Guijarro R; Alarcón F; Lindström K; Ortiz-Villalón C
    Ann Diagn Pathol; 2021 Apr; 51():151701. PubMed ID: 33485052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1 Tumor Cell Expression in Upper Tract Urothelial Carcinomas is Associated With Higher Pathologic Stage.
    Ward M; Albertson D; Furtado LV; Deftereos G
    Appl Immunohistochem Mol Morphol; 2022 Jan; 30(1):56-61. PubMed ID: 34183505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.